Jonathan Mow is the founder of PhaseBio Pharmaceuticals. PhaseBio Pharmaceuticals has raised $168M in total funding. Latest round: Series D.
Jonathan Mow is the CEO of PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company focused on treatments for cardiopulmonary diseases. He later became CEO of Veralox Therapeutics after the company secured $24 million in funding. Mow has been a part of PhaseBio's executive management team since at least 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library